Submission to Australian Parliament's Human Rights Sub-Committee on women and girls in the Pacific
Policy & Practice Report
Responding to UK DHSC’s Women’s Health Strategy Call for Evidence
Policy & Practice Report
ASPIrin to Reduce Events in Dialysis (ASPIRED)
The ASPIRED Trial will determine the safety and efficacy of low dose aspirin for the prevention of cardiovascular events in people with end stage kidney disease receiving dialysis.
Introducing a total online advertising restriction for products high in fat, sugar, and salt
Policy & Practice Report
Health and Well-being of Waste Workers in India
Policy & Practice Report
Primary Health Reform – Response to the Recommendations by The George Institute
Policy & Practice Report
Submission to the Senate inquiry on definitions of meat and other animal products
Policy & Practice Report
Food is Medicine: developing a Medically-Tailored Meal (MTM) program to tackle type 2 diabetes and heart disease in Australia
Eating an unhealthy diet is a leading risk factor for chronic diseases worldwide. Innovative new programs to improve the diet of millions of Australians at high risk of heart disease, such as those with high blood pressure and type 2 diabetes (T2D), have tremendous potential to save lives and reduce healthcare costs.
The George Institute and partners call for recognition of unheard voices at the UN Food Systems Summit
Policy & Practice Report
Understanding the economics of Tuberculosis (TB) patients in the private sector
Background
Despite free treatment offered by the government, the private sector plays a significant role in Tuberculosis (TB) treatment in India. The reasons for availing private facilities are dissatisfaction with public sector services, non-availability of public facilities in the neighbourhood, long waiting time etc. A literature review identified that only three studies (covered total of 102 patients) estimated the cost for the TB patients treated in the private sector. Two studies considered only multi-drug resistant TB patients, the third one collected out of pocket expenses data from a convenient sample of 32 drug susceptible TB patients. Therefore, there is a clear dearth of data on the economic burden of TB in the private sector in India.
Aim
The national strategic plan for TB (2017-2025) stated its intention to extend the umbrella of high-quality TB care and control to those treated in the private sector, highlighting private sector engagement (PPE) as an important strategy to eliminate TB.
Community Action for Health in India (CAHI): from the National Rural Health Mission to Universal Health Coverage
Background
The Civil Society Engagement Mechanism for UHC2030 is a global movement advancing citizen engagement, mobilising collective action and political commitment, and is acting as a platform to forge greater collaborations globally for Universal Health Coverage (UHC). With this mandate, the CSEM is interested in understanding lessons in social and community participation in health in various contexts across the world. India has globally been among the champions of community participation in health inspiring global commitments on health equity such as the Alma Ata Declaration on Health for All. The public mobilisation on the Health for All agenda in 2000 by Jan Swasthya Abhiyan (JSA) is a watershed in the history of social movements in India. The advocacy efforts of the JSA, Medico Friends Circle and a range of individuals and collectives from the civil society influenced the emergence and evolution of India’s National Rural Health Mission (NRHM) in 2005. The NRHM is notable on account of nationally
Prioritisation of snakebite in the World Health Organization
Background
Snakebite is a neglected tropical disease, with an estimated 138,000 deaths in a year globally, most of it in South Asia and Africa. In 2018, 31 countries unanimously passed a resolution to develop a roadmap to address the burden of snakebite in the 71st World Health Assembly. Consequently in 2019, the World Health Organization (WHO) developed a strategy to address snakebite and bring down its burden to 50% by 2030. The prioritisation of snakebite as a global health issue in the WHO is expected to lead to development of national and regional-level strategies as well as provision of funding across the world. However there is no research to understand how and why snakebite was prioritised in the WHO.
Aim
To understand how and why did snakebite became a priority in WHO leading to the development of the 71st WHA resolution to develop a roadmap to address its burden in 2018 and the subsequent development of the strategy in 2019?
Research Methodology
The study will use a case-study approac